Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Castel-Kremer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|May 5, 2009
[Specific toxicities of chemotherapy in senior adult patients]Elisabeth Castel-Kremer, Jean-Pierre Droz
La Revue Du Praticien|May 5, 2009
[Infiltrating bladder cancer: clinical case]Elisabeth Castel-Kremer, Jean-Pierre Droz
La Revue Du Praticien|May 5, 2009
[Decision making in geriatric oncology]Elisabeth Castel-Kremer, Jean-Pierre Droz
Journal of Geriatric Oncology|February 19, 2018
Reply to "Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations" by Mislang et alOlivia Le Saux, Christine Ravot, Elisabeth Castel-Kremer, et al.
The Lancet. Oncology|December 30, 2008
Effects of comorbidity on screening and early diagnosis of cancer in elderly peopleCatherine Terret, Elisabeth Castel-Kremer, Gilles Albrand, et al.
Soins. Gerontologie|May 4, 2007
[Physical therapy and mobile geriatric teams]Patricia Baechler, Elisabeth Castel-Kremer, Damiien Heitz, et al.
Journal of Geriatric Oncology|March 26, 2018
Systematic review of care needs for older patients treated with anticancer drugsOlivia Le Saux, Sandrine Lapotre-Aurelle, Sophie Watelet, et al.
Bulletin Du Cancer|March 13, 2022
[Multidisciplinary Team Meeting dedicated to geriatric oncology: Decisions and four month follow-up]Alice Schwartz, Pascale Mere, Fabien Subtil, et al.
Journal of Geriatric Oncology|April 25, 2018
An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinomaElisabeth Castel-Kremer, Solene De Talhouet, Anne-Laure Charlois, et al.
Neuroendocrinology|October 7, 2019
Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET StudyAnnie Lemelin, Delphine Maucort-Boulch, Elisabeth Castel-Kremer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|May 5, 2009
[Specific toxicities of chemotherapy in senior adult patients]Elisabeth Castel-Kremer, Jean-Pierre Droz
La Revue Du Praticien|May 5, 2009
[Infiltrating bladder cancer: clinical case]Elisabeth Castel-Kremer, Jean-Pierre Droz
La Revue Du Praticien|May 5, 2009
[Decision making in geriatric oncology]Elisabeth Castel-Kremer, Jean-Pierre Droz
Journal of Geriatric Oncology|February 19, 2018
Reply to "Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations" by Mislang et alOlivia Le Saux, Christine Ravot, Elisabeth Castel-Kremer, et al.
The Lancet. Oncology|December 30, 2008
Effects of comorbidity on screening and early diagnosis of cancer in elderly peopleCatherine Terret, Elisabeth Castel-Kremer, Gilles Albrand, et al.
Soins. Gerontologie|May 4, 2007
[Physical therapy and mobile geriatric teams]Patricia Baechler, Elisabeth Castel-Kremer, Damiien Heitz, et al.
Journal of Geriatric Oncology|March 26, 2018
Systematic review of care needs for older patients treated with anticancer drugsOlivia Le Saux, Sandrine Lapotre-Aurelle, Sophie Watelet, et al.
Bulletin Du Cancer|March 13, 2022
[Multidisciplinary Team Meeting dedicated to geriatric oncology: Decisions and four month follow-up]Alice Schwartz, Pascale Mere, Fabien Subtil, et al.
Journal of Geriatric Oncology|April 25, 2018
An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinomaElisabeth Castel-Kremer, Solene De Talhouet, Anne-Laure Charlois, et al.
Neuroendocrinology|October 7, 2019
Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET StudyAnnie Lemelin, Delphine Maucort-Boulch, Elisabeth Castel-Kremer, et al.
Pageof 2